Arkolith/Insider Trading/TCON/Form 4

Theuer Charles

PRESIDENT AND CEO, DirectorTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Mar 13, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 20, 2023Grant(A)4K$0.13$455406K
Apr 20, 2023Grant(A)4K$0.14$490403K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2024Grant(A)518K—$0518K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-007846) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML